News
![](/sites/default/files/styles/full_article/public/2020-11/Immune%20checkpoint%20inhibitors.png?itok=bdwO_ge6)
Whole genome and transcriptome sequencing uncovers biomarkers predicting response to immune checkpoint inhibitors
The development of immune checkpoint inhibitors (ICI), a type of cancer therapy that helps the immune system fight tumours, was one of the most significant milestones in cancer treatment in the last decade. While ICI therapy has been used to treat different cancer types, it is not universally effective and relapsed disease occurs. A robust strategy for predicting which patients are likely to respond to ICIs is needed, enabling clinicians to select the best course of treatment for each patient.
![](/sites/default/files/styles/full_article/public/2020-11/Screen%20Shot%202020-11-26%20at%2010.03.10%20AM.png?itok=RE4UEtHC)
Voicing the Silent Genomes: new documentary features GSC Scientist, Dr. Nadine Caron
Remembering a glorious celebration: the GSC’s 20th Anniversary
This time last year we were in the midst of celebrating the GSC’s twentieth anniversary! Now, with all of us maintaining safe distances during the COVID-19 global pandemic, we can look back on these events with a greater appreciation for a glorious time when we were all able to be together.
![](/sites/default/files/styles/full_article/public/2020-11/Laura%20Evgin%20bottom%20crop.jpeg?itok=9_3DD_uj)
The GSC Welcomes Dr. Laura Evgin
![](/sites/default/files/styles/full_article/public/2020-11/Wyatt_web_news-crop-05112020.png?itok=A3T2KuMh)
The GSC Welcomes Dr. Alexander Wyatt
![](/sites/default/files/styles/full_article/public/2020-12/CCR%20deep%20learning%282%29.png?itok=cRdL8T2A)
A deep learning-based approach for colorectal cancer diagnostics
![](/sites/default/files/styles/full_article/public/2020-12/points%20of.png?itok=ngUASqPc)
Fifty Points of Significance
![](/sites/default/files/styles/full_article/public/2020-12/Leung%20et%20al.%281%29.png?itok=S3R1fd6N)
An optimized tool for the development of novel therapies for treatment-resistant prostate cancer
![](/sites/default/files/styles/full_article/public/2020-12/Guenter%20et%20al..png?itok=i3izJQwO)